Search results
Pharming (PHAR) Rare Disease Drug Joenja Gets FDA Nod, Stock Up
Zacks via Yahoo Finance· 1 year agoPharming Group (PHAR) obtains FDA approval for leniolisib for the treatment of a rare pediatric...
Can Pharming Group N.V. Sponsored ADR (PHAR) Run Higher on Rising Earnings Estimates?
Zacks via Yahoo Finance· 2 years agoPharming Group N.V. Sponsored ADR (PHAR) shares have started gaining and might continue moving...
Pharming Group N.V. (AMS:PHARM) Analysts Are Pretty Bullish On The Stock After Recent Results
Simply Wall St. via Yahoo Finance· 2 months agoPharming Group N.V. (AMS:PHARM) came out with its yearly results last week, and we wanted to see how...
Pharming Group N.V. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Simply Wall St. via Yahoo Finance· 2 years agoInvestors in Pharming Group N.V. (AMS:PHARM) had a good week, as its shares rose 2.2% to close at...
Pharming Group N.V.'s (AMS:PHARM) Fundamentals Look Pretty Strong: Could The Market Be Wrong About...
Simply Wall St. via Yahoo Finance· 1 year agoWith its stock down 8.5% over the past three months, it is easy to disregard Pharming Group...
Pharming Group N.V. Sponsored ADR (PHAR) Soars 14.7%: Is Further Upside Left in the Stock?
Zacks via Yahoo Finance· 8 months agoPharming Group N.V. Sponsored ADR (PHAR) saw its shares surge in the last session with trading...
Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains?
Zacks via Yahoo Finance· 3 weeks agoPharming Group (PHAR) saw its shares surge in the last session with trading volume being higher than...
Pharming Group Full Year 2023 Earnings: US$0.015 loss per share (vs US$0.021 profit in FY 2022)
Simply Wall St. via Yahoo Finance· 2 months agoPharming Group (AMS:PHARM) Full Year 2023 Results Key Financial Results Revenue: US$245.3m (up 19%...
FDA Approves Pharming's Immune Disorder Drug, As First APDS Therapy
Benzinga via Yahoo Finance· 1 year agoThe FDA approved Pharming Group N.V.'s (NASDAQ: PHAR) Joenja (leniolisib) for activated...
Investing in Pharming Group (AMS:PHARM) a year ago would have delivered you a 59% gain
Simply Wall St. via Yahoo Finance· 1 year agoPassive investing in index funds can generate returns that roughly match the overall market. But...